Cargando…
Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder
Current pharmacological treatments for bipolar disorder (BD) are limited and efficacy has historically been discovered through serendipity. There is now scope for new drug development, focused on the underlying biology of BD that is not targeted by current therapies. The need for novel treatments is...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Bentham Science Publishers
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761635/ https://www.ncbi.nlm.nih.gov/pubmed/26467413 http://dx.doi.org/10.2174/1570159X13666150630175841 |